Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (81-90 of 369) with videos related to

Pageof 37
Sort By:
British Journal of Cancer|January 1, 1995
Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effectS Sleijfer, T W van der Mark, H Schraffordt Koops, et al.
International Journal of Cancer|January 2, 1993
Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell lineS de Jong, H Timmer-Bosscha, E G de Vries, et al.
British Journal of Cancer|February 1, 1991
NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell lineS de Jong, N H Mulder, E G de Vries, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Severe renal failure following high-dose ifosfamide and mesnaP H Willemse, P E de Jong, J D Elema, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 1, 1996
Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an updateJ Nieken, D T Sleijfer, J Buter, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatinS Sleijfer, T W van der Mark, H Schraffordt Koops, et al.
Cancer|September 15, 1983
Five years' experience in access surgery for polychemotherapy. An analysis of results in 100 consecutive patientsT Wobbes, M J Slooff, D T Sleijfer, et al.
British Journal of Haematology|January 1, 1982
Endotoxin in paroxysmal nocturnal haemoglobulinuria (PNH)E Vellenga, N H Mulder, H O Nieweg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistanceS de Jong, J G Zijlstra, N H Mulder, et al.
World Journal of Surgery|July 1, 1983
The radiocephalic fistula as vascular access for chemotherapyT Wobbes, M J Slooff, D H Lichtendahl, et al.
Pageof 37

Showing results (81-90 of 369) with videos related to

Sort By:
Pageof 37
British Journal of Cancer|January 1, 1995
Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effectS Sleijfer, T W van der Mark, H Schraffordt Koops, et al.
International Journal of Cancer|January 2, 1993
Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell lineS de Jong, H Timmer-Bosscha, E G de Vries, et al.
British Journal of Cancer|February 1, 1991
NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell lineS de Jong, N H Mulder, E G de Vries, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Severe renal failure following high-dose ifosfamide and mesnaP H Willemse, P E de Jong, J D Elema, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 1, 1996
Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an updateJ Nieken, D T Sleijfer, J Buter, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatinS Sleijfer, T W van der Mark, H Schraffordt Koops, et al.
Cancer|September 15, 1983
Five years' experience in access surgery for polychemotherapy. An analysis of results in 100 consecutive patientsT Wobbes, M J Slooff, D T Sleijfer, et al.
British Journal of Haematology|January 1, 1982
Endotoxin in paroxysmal nocturnal haemoglobulinuria (PNH)E Vellenga, N H Mulder, H O Nieweg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistanceS de Jong, J G Zijlstra, N H Mulder, et al.
World Journal of Surgery|July 1, 1983
The radiocephalic fistula as vascular access for chemotherapyT Wobbes, M J Slooff, D H Lichtendahl, et al.
Pageof 37